7-ethyl-10-hydroxycamptothecin Recruiting Phase 1 Trials for Solid Tumor, Recurrent / Neoplasms / Malignancies / Tumors / Refractory Solid Tumors Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT03096340Safety and Pharmacokinetic Study of IT-141 in Monotherapy in Patients With Advanced Cancer